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1875-9572/Copyright ª 2014, TaiwanNystagmus is an involuntary rhythmic oscillation of the eyes, which leads to reduced visual
acuity due to the excessive motion of images on the retina. Nystagmus can be grouped into
infantile nystagmus (IN), which usually appears in the first 3e6 months of life, and acquired
nystagmus (AN), which appears later. IN can be idiopathic or associated to albinism, retinal dis-
ease, low vision, or visual deprivation in early life, for example due to congenital cataracts,
optic nerve hypoplasia, and retinal dystrophies, or it can be part of neurological syndromes
and neurologic diseases. It is important to differentiate between infantile and acquired
nystagmus. This can be achieved by considering not only the time of onset of the nystagmus,
but also the waveform characteristics of the nystagmus. Neurological disease should be sus-
pected when the nystagmus is asymmetrical or unilateral. Electrophysiology, laboratory tests,
neurological, and imaging work-up may be necessary, in order to exclude any underlying ocular
or systemic pathology in a child with nystagmus. Furthermore, the recent introduction of hand-
held spectral domain optical coherence tomography (HH SD-OCT) provides detailed assessment
of foveal structure in several pediatric eye conditions associated with nystagmus and it can
been used to determine the underlying cause of infantile nystagmus. Additionally, the devel-
opment of novel methods to record eye movements can help to obtain more detailed informa-
tion and assist the diagnosis. Recent advances in the field of genetics have identified the
FRMD7 gene as the major cause of hereditary X-linked nystagmus, which will possibly guide
research towards gene therapy in the future. Treatment options for nystagmus involve pharma-
cological and surgical interventions. Clinically proven pharmacological treatments for
nystagmus, such as gabapentin and memantine, are now beginning to emerge. In cases of
obvious head posture, eye muscle surgery can be performed to shift the null zone of the
nystagmus into the primary position, and also to alleviate neck problems that can arise due
to an abnormal head posture.
Copyright ª 2014, Taiwan Pediatric Association. Published by Elsevier Taiwan LLC. All rights
reserved.gy Group, University of Leicester, Leicester Royal Infirmary, P. O. Box 65, Leicester, LE2 7LX, United
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342 E. Papageorgiou et al1. IntroductionNystagmus is defined as an involuntary rhythmic oscillation
of the eyes, and it can be confirmed relatively easily
through direct observation of eyes and/or eye movement
recordings. Nystagmus is commonly encountered in clinical
practice and leads to reduced visual acuity due to the
excessive motion of images on the retina, and also the
movement of images away from the fovea.1 The prevalence
of nystagmus in the general population is estimated to be
24 per 10,000 population with a slight predilection toward
European ancestry.2 The prevalence of infantile nystagmus
is 14 per 10,000.2
Nystagmus can be grouped into infantile nystagmus (IN),
which usually appears in the first 3e6 months of life, and
acquired nystagmus (AN), which appears later. For those
who have infantile nystagmus (IN), this can be idiopathic or
associated to another eye disease, such as retinal disease,
albinism, low vision, or visual deprivation in early life (due,
for example, to congenital cataracts or optic nerve hypo-
plasia). Nystagmus can also be part of neurological syn-
dromes and neurologic diseases (Figure 1).3 In IN associated
with other eye diseases, vision is not only affected by the
excessive motion of the image on the retina caused by the
nystagmus, but also by a defective visual system.4 Mecha-
nisms underlying IN are not very clear. Numerous hypoth-
eses and models have been proposed to explain the ocular
oscillations observed in IN, usually highlighting various el-
ements of the ocular motor circuitry as the direct cause.5
However, the clear association between IN and the many
sensory anomalies that lead to sight loss during visual
development imply an afferent cause to many IN forms.6
Acquired nystagmus can result from a range of neuro-
logical disorders, of which the most common are multipleFigure 1 Classification of childhood nystagmus. Note. From “Th
McLean and I. Gottlob, 2009, Expert Opin Pharmacother, 10, p.
permission.sclerosis, disease of the vestibular apparatus and in-
nervations, insult to the nervous system caused by stroke,
tumors, or trauma, and as a result of drug toxicity.7 In
general, the mechanisms underlying AN are better under-
stood than those behind IN. AN is commonly associated with
lesions to the subcortical ocular motor circuitry.8 Conse-
quently, detection and diagnosis of diseases associated
with AN are greatly assisted by neuroimaging methods.
Nystagmus can be distressing for both those with IN and
AN. Nystagmus leads to deterioration in visual acuity and
motion sensitivity mainly because of deterioration in foveal
vision, when images move across the retina rapidly.9
Nystagmus can also have a significant psychological and
social impact.10 Although patients with IN and AN both have
reduced vision, patients with AN tend to suffer from oscil-
lopsia (the illusion of constant movement of the surround-
ings) and hence may be more troubled by the condition.11
Patients with IN do not usually suffer from oscillopsia.
Two hypotheses have been suggested to explain the
mechanism behind the suppression of oscillopsia. The first
is the “sampling theory”, by which the information from
the most stable retinal images during the foveation periods
can be used to establish a stable image, whereas the rest of
the nystagmus cycle is ignored.12 The second hypothesis is
the “remapping theory” whereby an efference copy signal
of the nystagmus waveform is used to cancel the effects of
motion.13 This is probably the most likely theory because
vision during the fast phases of the nystagmus cycle has
been documented which argues against sampling. Finally, a
recent Positron Emission Tomography/Magnetic Resonance
Imaging (PET/MRI) study in a patient with infantile
nystagmus during maximal nystagmus showed a metabolic
downregulation of the area MT/V5 bilaterally, the most
important part of the visual cortex for visual motione pharmacological treatment of nystagmus: a review”, by R.J.
1805e16. Copyright 2009, Informa UK Limited. Adapted with
Childhood nystagmus 343processing.14 The authors suggested that the relative
decrease in metabolic activity in this network of visual-
motion processing represents the functional correlate for
the clinical absence of oscillopsia in patients with a
congenital pendular nystagmus (Figure 2).14
It is important to differentiate between infantile and
acquired nystagmus. This can be achieved by considering
not only the time of onset of the nystagmus, but also the
waveform characteristics of the nystagmus. Nystagmus
waveforms can be viewed in detail via eye movement re-
cordings, which can be documented using different
methods, such as electrooculography, the scleral search
coil, and video eye-tracking devices (Figure 3A and B).15
Nystagmus waveforms are extremely variable (Figure 4).16
They can be described using a number of characteristics
which can also assist in the diagnosis.17 (1) Plane:
nystagmus most commonly occurs along the horizontal axis,
although nystagmus can also be vertical, torsional, or any
combination of these, such as seesaw nystagmus (vertical
with torsional) or cyclorotatory nystagmus (horizontal with
vertical).18 (2) Amplitude (size) and frequency (cycles per
second):19 amplitude and frequency should be assessed in
primary position and with the patient looking to the sides as
well as up and down. Often a reduction of nystagmus can be
seen with the patient fixing at near (in convergence).
Nystagmus intensity can vary with eye position and often
there is a position of gaze in which the oscillations are
minimal (null point).18 (3) Waveform: nystagmus has been
divided into jerk nystagmus, which exhibits a quick and
slow phase, and pendular nystagmus, which is a sinusoidal
like oscillation without any obvious quick phase (Figure 4).
In jerk nystagmus, the direction of nystagmus is defined by
the quick phase of the jerk (e.g., downbeat).20 The slow
phase can have accelerating and decelerating velocities
(Figure 4). (4) Conjugacy: when the eyes move in tandem,
the nystagmus is described as conjugate or associated.
Disconjugate or dissociated nystagmus occurs when the eye
movements differ in amplitude, frequency, waveform, or
when the oscillations of the two eyes are out of phase withFigure 2 Thresholded regional cerebral glucose metabolism (rCG
decreased metabolism in MT/V5 bilaterally and an increase in the ce
V5 while fixating in the null zone. Note. From “Visual motion supp
Schreckenberger, and M Dieterich M, 2009, Ann New York Acad Sci,1
Reproduced with permission.each other. For example, the amplitude can be larger in
one eye in anterior visual pathway pathology and spasmus
nutans. Additionally, both eyes may move in opposite di-
rections in spasmus nutans, seesaw nystagmus, or conver-
gence nystagmus in Parinaud syndrome.18 (5) Foveation:
many forms of congenital nystagmus show periods where
the eyes move at a lower velocity allowing high-acuity
vision at the fovea to function.9 (6) Dependence on other
parameters: certain types of nystagmus waveform are not
constant but vary with time (e.g., intermittent or reverse
direction), monocular or binocular viewing, and conver-
gence or eccentricity of gaze. For example, periodic
alternating nystagmus is a horizontal jerk nystagmus that
goes through cycles of left- and right-beating nystagmus,
reversing approximately every 1e2 minutes.18
2. Infantile nystagmus
2.1. Infantile idiopathic nystagmus
IIN is the most common type of infantile nystagmus, fol-
lowed by nystagmus associated with ocular disease.2 In
infantile idiopathic nystagmus (IIN) no underlying eye con-
dition or neurological problems are present. IIN is usually
bilateral, conjugate, occurring in the horizontal plane, and
of either a pendular waveform or a jerk waveform with an
accelerating slow phase, but it may also rarely appear as
primarily vertical or even torsional nystagmus.17,21 The
term “idiopathic infantile nystagmus” is used in preference
to “congenital idiopathic nystagmus” as the nystagmus is
not always present at birth.22 The onset of IIN is usually
between birth and 12 weeks of age.23 Visual acuity is log-
MAR 0.3 (6/12) or better in most patients and nystagmus
usually becomes less evident with age.21 Strabismus is not
common and good stereopsis is often present.
Individuals with IIN develop a “foveation strategy” dur-
ing visual development in order to improve vision.24 In-
dividuals learn how to use “foveating saccades” toM) during gaze (A) with maximal pendular nystagmus (red) and
rebellar nodulus compared to (B) glucose uptake in V1 and MT/
ression in congenital pendular nystagmus”, P. Schlindwein, M.
164, p. 458e60. Copyright 2009. New York Academy of Sciences.
Figure 3 (A) Eyelink 1000, SR Research Ltd, Ottawa, Ontario,
Canada, a head free remote eye tracking system which does
not require head stabilization. A small target sticker can be
placed on the forehead so that head distance can be accurately
measured. The eye tracking system is mounted on the bottom
of the computer screen which is being used for the stimuli.
Ideal for use in infants and small children. (B) Head-mounted
video eye tracker (Eyelink II, SR Research Ltd) provides
binocular recordings sampling at 500 Hz. (C) The hand-held
OCT is performed on a toddler (Bioptigen Inc, Research Trian-
gle Park, North Carolina, USA).
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slowly. Individuals use these slow periods (called foveation
periods) to line up the fovea with targets of interest.
A study investigating visual acuity development of chil-
drenwith IN syndrome reported that patientswith IIN showed
mildly reduced visual acuity before 24 months of age and a
gradual maturation of visual acuity with age after 24months,
which paralleled with existing normative curves for visual
acuity development.25 Indeed, most of the visual acuity test
results were within the 95% normative tolerance limit before
48 months of age. After 48 months of age, visual acuity
improved, even though only half of the visual acuity test re-
sults were within the 95% normative tolerance limits.25
IIN is usually associated with a null region where the
nystagmus has a lower intensity. If the null point does not
coincide with the primary gaze position, then a head posi-
tion may be adopted to reduce the nystagmus.26 This can
result in a face turn most commonly when the nystagmus is
in the horizontal plane. Sometimes patients with horizontal
nystagmus also adopt chin up and down positions, the
reason for which is poorly understood.27 Patients with IIN
can have a strong family history of nystagmus or can be
singly affected. The most common mode of inheritance is
due to X-linked mutations.28 The cause of IIN is still un-
known. A suggested mechanism is the developmental mis-
wiring of the visual system.29 However, there is no
consensus concerning the dysfunctional neuronal structures
in IIN, with suggestions including the fixational eyeFigure 4 Eye movement recordings showing different
nystagmus waveforms. Pendular nystagmus is a sinusoidal like
oscillation without any obvious quick phase, whereas jerk
nystagmus exhibits a quick and slow phase. The slow phase can
have accelerating and decelerating velocities.
Figure 5 This child with albinism-associated nystagmus and
a left head turn (A) underwent a Kestenbaum procedure for
correction of his head posture. (B) No head turn is present after
the operation.
Childhood nystagmus 345movement system, the pursuit system, and the saccadic
system.30 Recently, it has also been suggested that IIN is a
developmental response to poor high-contrast foveal
vision, where contrast sensitivity to low spatial frequencies
is enhanced by moving images across the retina.6
Recently the gene FRMD7 has been identified as themajor
cause of hereditary X-linked nystagmus, which is the most
frequent familial type. Although the exact function of this
gene is still unknown, it is expressed in the retina, cere-
bellum, and lateral ventricles during development.31 FRMD7
has been shown to be involved in neurite outgrowth and
development and interaction with CASC (plasma membrane
scaffolding protein) has been shown.32e34 Individuals with
mutations in the FRMD7 gene have relatively good visual
acuity (better than 6/12), often possess stereopsis and show
less pronounced anomalous head posture compared to in-
dividuals with IIN not caused by FRMD7 mutations. Periodic
alternating nystagmus occurs in approximately 25% of pa-
tients with FRMD7 related nystagmus.21
2.2. Manifest latent nystagmus
Manifest latent nystagmus (MLN) is a predominantly hori-
zontal, jerk nystagmus that becomes more apparent when
one eye is covered. The fast phase beats towards the di-
rection of the fixing/open eye. In almost all patients,
nystagmus is present with both eyes open: it is smaller in
intensity and may be subclinical in size.35 The manifest
component of the nystagmus is evident when both eyes are
open. The latent component (increase in nystagmus
amplitude) is revealed when one eye is occluded.
MLN is almost always associated with congenital squint
syndrome, which leads to disrupted binocular vision. In pa-
tients with alternating esotropia, the nystagmus fast phases
can change spontaneously depending on which eye is fixing.
Additionally, it is often associated with conditions that cause
unilateral loss of vision during visual development such as
cataract and optic nerve hypoplasia, and it is also found in
conjunctionwith IIN, inwhich case a complexnystagmuswave
form is seen.36 MLN is often associated with Down syndrome,
as children with Down syndrome often have strabismus.37
MLN dampens in adduction; hence patients with stra-
bismus and MLN will place the fixing eye in adduction to
improve vision, and this will lead to a face turn to the side of
the fixing eye (Figure 5A). Patients may also show a head tilt
which could be part of the congenital squint syndrome un-
related to MLN ormay be to compensate for the cyclovertical
(i.e., torsional and vertical) component often seen in MLN.38
The underlying mechanism behind MLN is the disruption
of binocular vision during visual development, through
strabismus and amblyopia. MLN can be treated by cor-
recting the squint: this can be combined with correction of
the head posture using eye muscle surgery, in which case
the fixing eye needs to be operated.39 Treating the under-
lying amblyopia using patching therapy can also reduce the
nystagmus caused by MLN.40
2.3. Albinism
Oculocutaneous albinism (OCA) is characterized by a lack of
pigmentation in the eyes, skin, and hair and is caused bydisruption in the production of melanin due to a number of
genetic mutations.41 In certain forms of albinism there is no
apparent lack of pigmentation in hair or skin and only the
visual system is affected. This is described as ocular albi-
nism (OA).
OCA is associated with several changes in the eye and vi-
sual pathway, including iris transillumination (Figure 6),
foveal hypoplasia, retinal hypopigmentation (Figure 7),
abnormal crossing of the optic nerves at the chiasm, reorga-
nization of the striate cortex, and nystagmus. Optical
coherence tomography shows a spectrum of foveal develop-
ment in albinism, sometimes with complete absence of
development or with a central depression with thickened
fovea (Figure 8).42,43 The abnormal foveal development
frequently leads to reduced visual acuity. The optic discs can
be small and dysplastic (small cupless disks or oblique cup
with situs inversus).44 One of the most distinguishable fea-
tures of albinism is abnormal crossing of axons at the
chiasm.45 This can be detected diagnostically as an asym-
metry in the visual evoked potential. Albinism is often
Figure 6 Anterior segment photos in albinism show various degrees of iris transillumination.
Figure 7 Fundus photographs in albinism demonstrate Grades 1, 2 and 3 macular transparency according to a previously
described grading scheme.42
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Figure 8 Classification of foveal hypoplasia according to Thomas et al. In Grade 1 foveal hypoplasia extrusion of plexiform retinal
layers is absent, but a shallow foveal pit, outer nuclear layer (ONL) widening and lengthening of the cone outer segment (OS) are
seen. Grade 2 foveal hypoplasia consists of all features of Grade 1 except the presence of a foveal pit. Grade 3 foveal hypoplasia
involves all features of Grade 2 foveal hypoplasia except the widening of the cone outer segment. In Grade 4 foveal hypoplasia, all
the features of Grade 3 are seen except the widening of the ONL at the fovea. Note. From “Structural grading of foveal hypoplasia
using spectral-domain optical coherence tomography a predictor of visual acuity?”, M.G. Thomas, A. Kumar, S. Mohammad, F.A.
Proudlock, EC Engle, C. Andrews, et al, 2011, Ophthalmology, 118, p. 1653e60. Copyright 2011. American Academy of Ophthal-
mology. Adapted with permission.
Childhood nystagmus 347associated with a loss of cortical stereoscopic vision due to
misrouting of axons through to the cortex and also strabismus.
The nystagmus shows many similarities to that observed
in IIN patients. It is usually horizontal, conjugate, with
increasing slow-phase velocities and the nystagmus intensity
and waveform changing with gaze direction. These patients
also typically show a null zone and often have an anomalous
head posture. However, in cases of IIN associated with
FRMD7 mutations, there were slight differences in
nystagmus characteristics. The FRMD7-IIN patients showed a
higher proportion of pendular waveform types compared
with the albinos.46 Additionally, the nystagmus frequency
was significantly lower in albinos compared with the FRMD7-
IIN group. Strabismus and anomalous head posture were
seen in higher proportions in the albinism group, and ste-
reopsis was worse compared with the FRMD7-IIN group.46
OCA is linked to mutations in four known genes and OA in
one known gene. All these mutations lead to dysfunctional
melanin synthesis and storage. OCA1 is present in most pop-
ulations except AfricaneAmericans and can present with
either a complete lack of melanin production (OCA1A) or
partialmelanin production (OCA1B). It is causedbymutations
in the tyrosinase gene (TYR). OCA2 and OCA3 are more com-
mon in African populations and are milder forms of albinism.
OCA4 is another mild form of albinism that has recently been
found in Turkish, Japanese, German, and Korean patients.
There are two known causes ofOA: (1) due tomutations in the
OA1 gene which follows an X-linked recessive inheritance; or
(2) autosomal-recessive ocular albinism (AROA).472.4. Spasmus nutans
Spasmus nutans is a rare form of infantile nystagmus that is
characterized by a triad of nystagmus, head nodding, and
head torticollis. It is an intermittent, fine, high-frequency,
pendular dissociated nystagmus. It appears atw 1e3 years
of age but abates to subclinical levels at w 5e12 years of
age.48 Spasmus nutans is not inherited and is more common
in low socioeconomic classes.49 Interestingly, head nodding
evoques the vestibular ocular reflex that may dampen the
spasmus nutans and thus improve vision.20 In other
nystagmus forms head nodding has not been found to
benefit the patient and might be an associated pathological
phenomenon.50 Spasmus nutans can be differentiated from
infantile nystagmus by the high frequency of eye move-
ments. Additionally, although congenital idiopathic
nystagmus and sensory deficit nystagmus usually have an
onset before 6 months of age, it is generally agreed that the
onset of spasmus nutans is always after 6 months of age and
usually before 2e3 years of age.50,51 However, because the
eye movements are often dissociated, spasmus nutans
cannot be separated from nystagmus associated with
retinal disease (such as achromatopsia and congenital sta-
tionary night blindness) or nystagmus caused by lesions to
the anterior visual pathway caused by tumors, for example,
optic nerve and chiasmal gliomas.51,52 Therefore, thorough
neuroophthalmological (including electrophysiology), neu-
ropaediatric, and possibly neuroradiological workup of the
patient is necessary.
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low vision
In infancy >90% of all cases of nystagmus seen will be due
to abnormalities at numerous locations along the sensory
visual pathway.53 In nystagmus associated to afferent dis-
eases, it is not entirely clear whether the afferent deficits
cause the nystagmus or whether the nystagmus is intrinsic
to the disease.3 Nystagmus associated to retinal diseases
and low vision is more common than the infantile idiopathic
nystagmus.2,54 However, it does show similar oculomotor
features.55 Nystagmus associated with retinal diseases and
low vision can be horizontal or vertical or a combination of
both, or it can also be dissociated.56 The visual acuity in
patients with nystagmus associated to afferent diseases is
often lower than in idiopathic nystagmus due to the
anatomical pathology of the eye. In the vast majority of
cases, nystagmus associated to afferent diseases is associ-
ated with bilateral anterior visual pathway pathology,
although occasionally binocular nystagmus is associated
with monocular visual loss (especially in untreated persis-
tent hyperplastic primary vitreous).57 Congenital cataracts
can lead to nystagmus if not operated on early enough.36
Corneal opacities, PAX6 mutations, developmental disor-
ders of the optic disc and retina such as bilateral optic
nerve hypoplasia and chorioretinal or optic nerve colo-
boma, and retinopathy of prematurity are also associated
with nystagmus. Deficits of rod and cone systems, such as
congenital stationary night blindness, achromatopsia
(complete or partial, e.g., blue-cone monochromatism),
Leber’s amaurosis, BardeteBiedl syndrome, Joubert’s syn-
drome, and Alstro¨m’s syndrome are all associated with
nystagmus.58 Careful history-taking is important, as for
example photophobia with poor color discrimination may
indicate achromatopsia or blue-cone monochromatism, and
night blindness with high myopia may suggest congenital
stationary night-blindness. Achiasmatic individuals have
been described to have congenital seesaw nystagmus.59
These congenital disorders require differentiation by clin-
ical findings, family history, laboratory tests, radiology, and
detailed electrophysiological findings under photopic and
scotopic conditions.57
2.6. Nystagmus associated with neurologic diseases
and syndromes
A variety of developmental and neurological syndromes are
associated with nystagmus, such as Down’s syndrome,
Noonan’s syndrome, PelizaeuseMerzbacher syndrome,
fetal alcohol syndrome, Sotos syndrome, Cockayne’s syn-
drome, and microcephaly. These are usually related to
abnormalities in the brainstem and cerebellum. Space-
occupying lesions, cerebral palsy, periventricular leuko-
malacia, leukodystrophy, Chiari malformation, as well as
metabolic and mitochondrial diseases are also associated
with nystagmus.18,60 Neurological disease should be sus-
pected when the nystagmus is asymmetrical (dissociated)
or unilateral. Acquired nystagmus is less frequent in chil-
dren (17% of nystagmus patients) than in adults (40%).2
Visual pathway disease giving rise to nystagmus includes
chiasmal and optic nerve glioma (i.e., in neurofibromatosistype 1), craniopharyngioma, and optic nerve compression
by other tumors or bone anomalies. Many patients with
neurological nystagmus also have associated neurological
symptoms or present with vertigo, nausea, and headaches
due to elevated intracranial hypertension. Ocular signs,
such as relative afferent pupillary defect, papilloedema,
optic atrophy, and visual loss may also be present. Addi-
tionally, children with arrested or compensated hydro-
cephalus can present with IN of the sensory deficit
nystagmus type. There is usually associated optic atrophy.
Therefore, optic atrophy and nystagmus in infancy indicate
a strong possibility of either raised intracranial pressure
and/or intracranial tumor in infancy.57 Therefore, an MRI
examination should be performed in the presence of atyp-
ical nystagmus, accompanying neurological signs, develop-
mental delay, or optic atrophy.
2.7. Optical coherence tomography (OCT) in
nystagmus
Optical coherence tomography (OCT) allows high-resolution
in vivo imaging of the retina. In particular, the recent
introduction of hand-held spectral domain OCT (HH SD-
OCT) provides reliable measurements in children and al-
lows detailed assessment of foveal structure in several
pediatric eye conditions associated with nystagmus
(Figure 3C).61 Characteristic foveal abnormalities have
been described in patients with albinism, ranging from
complete absence of development to a central depression
corresponding to a rudimentary annular reflex detected
with ophthalmoscopy.43,62,63 The degree of foveal hypo-
plasia has been correlated to visual acuity.64e66 Further-
more, in achromatopsia a characteristic lesion has been
described, which is associated with cone photoreceptor
degeneration. The signs of photoreceptor degeneration
were progressive, which suggests that gene therapy is likely
to be most beneficial if given within the first few years of
life.67 Abnormal foveal morphology was also present in
cases of retinal dystrophy and PAX6 mutations.43 Most
importantly, the classification of foveal abnormalities by
means of HH SD-OCT can been used to determine the un-
derlying cause of infantile nystagmus.43 Therefore, the
combination of OCT and genetic methods along with other
clinical diagnostic tools permit the discrimination of in-
fantile nystagmus subtypes with a precision that has not
previously been possible.68
3. Treatment in infantile nystagmus
3.1. Surgical
In cases of obvious head turn, eye muscle surgery can be
performed to shift the null zone of nystagmus into primary
position. The procedure is performed not only for cosmetic
reasons, but also to alleviate neck problems that can arise
due to an abnormal head posture. There may also be
improvement in visual acuity in some patients. For
example, surgically correcting the head position in patients
who wear glasses can enable them to view through their
glasses centrally and achieve better optical correction
(Figure 5A and B).4 Several attempts have also been made
to improve visual acuity. Recession of all four horizontal
Childhood nystagmus 349muscles and, more recently, tenotomy (disinsertion and
reattachment on the original insertion) of the four hori-
zontal muscles have been reported to improve visual
function and eye movements in IIN.39,69 However, there are
no randomized controlled studies to confirm these results.
Surgeries used to treat nystagmus and anomalous head
postures associated with IIN have also been used to treat
albinism and other nystagmus forms.69,70 Although im-
provements in intensity of nystagmus have been shown to
be effective by means of surgical intervention, improve-
ments in visual acuity are limited by the underdeveloped
fovea and other afferent deficits in these patients.70
3.2. Pharmacological
Although drugs have been administered for some time in
AN, pharmacological treatment for IN had not been
explored until recently. Gabapentin and memantine, drugs
which may have an antiglutaminergic action, both showed a
positive effect in patients with IIN (i.e., unassociated with
other visual deficits) and in patients with IN associated with
other visual deficits (albinism, achromatopsia, optic atro-
phy, optic nerve hypoplasia, and congenital cataracts). The
tolerability of the drugs was good and only mild side effects
were noted, such as, dizziness and tiredness.70 Treatment
for IN was trialed in a dosage of either up to 2400 mg
gabapentin per day in three divided doses or 20e40 mg of
memantine. The mechanism behind how these in-
terventions improve nystagmus is unclear. No trials have
been done on children.4
3.3. Refractive correction
Refractive error in nystagmus is often high and it is there-
fore important that refractive error is examined for and
appropriately prescribed for if required.71 As many of these
children have strabismus, occlusion, and other strabismus
management is important. There has been some contro-
versy with regard to the use of contact lenses in nystagmus;
there are reports that contact lenses improve visual acuity
and reduce nystagmus, particularly in IN.72 The improve-
ments in visual acuity with the use of contact lenses
compared to spectacles may be attributed to reduced op-
tical aberrations, enlarged retinal image, and increased
peripheral visual field.73 A recent randomized trial assess-
ing the use of hard and soft contact lenses in infantile
nystagmus showed that neither hard nor soft lenses dampen
nystagmus as compared to wearing glasses. Visual acuity
with soft contact lens wear in this study was worse than
with both hard lenses and glasses (oral communication with
Dr. R. McLean).
3.4. Prisms
Prisms can also be used to dampen nystagmus. In some
occurrences of IN, where the amplitude of nystagmus is
smaller in convergence, prisms can be introduced if the
patient has binocular vision. The prisms create an artificial
divergence that the patient is required to overcome by
converging the eyes even when looking at distance.743.5. Botulinum toxin Injections
Weakening muscles by retrobulbar injections of botulinum
toxin is another approach used in the treatment of
nystagmus. Studies of AN have shown that nystagmus re-
duces after botulinum injections, although the effects only
last for approximately 6 months.75 There are drawbacks to
this type of management, as ptosis and diplopia can occur,
which limits the therapeutic value and effectiveness of the
treatment.764. Conclusion
Nystagmus can result from a variety of conditions leading to
diverse but characteristic eye oscillations. Detailed eye
movement recordings may not be always be available to
clinicians. However, certain clinical features can be iden-
tified and provide clues concerning the underlying patho-
genesis. Manifest latent nystagmus, idiopathic infantile
nystagmus, and albinism can be diagnosed clinically and
neurological investigations are unnecessary. It is important
that both pediatricians and ophthalmologists exclude any
underlying ocular or systemic pathology in a child with
nystagmus. This may require electrophysiology, neurolog-
ical, and imaging work-up. OCT has been proven to be very
helpful to investigate whether patients have foveal hypo-
plasia or other retinal disorders. Clinically proven phar-
macological treatments for nystagmus are now beginning to
emerge, although their role in children is still limited.
Additionally, surgical procedures to correct a head turn in
nystagmus are effective, and surgeries to dampen
nystagmus such as tenotomy of four muscles are also being
performed. However, randomized controlled studies are
necessary to prove their effectiveness.Conflicts of interest
The authors report no conflicts of interest.References
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